EUIPO trademark

[O]

RegisteredEUIPOFigurative markClass 9Class 18Class 21Class 25+5

"[O]" is a figurative mark owned by Chan Zuckerberg Initiative, LLC, filed at the EUIPO on March 5, 2026. It is registered and covers classes 9, 18, 21, 25, 35, 36, 41, 42 and 44.

View Chan Zuckerberg Initiative, LLC portfolioGet this data via the API
Official EUIPO record
[O] trademark as filed
As filed with the EUIPO
Status
Registered
Since July 14, 2026
Filed
March 5, 2026
Registered
October 22, 2026
Expires
March 5, 2036
Application no.
019326099
Registration no.
019326099
Office
EUIPO
European Union Intellectual Property Office
Mark type
Figurative mark
9 classes
Ownership

Who owns [O]

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Chan Zuckerberg Initiative, LLC

140 trademarks in the portfolioView company

Representative

Bristows LLP

Bristows LLP

Goods and services

What the mark covers

The products and services [O] is filed for, grouped by Nice class.

  • Downloadable computer software for use in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; downloadable computer software using artificial intelligence for use in model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; downloadable computer software using artificial intelligence for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; downloadable computer software using artificial intelligence for use in biological data processing, generation, understanding and analysis; downloadable software for processing images, graphics and text in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; downloadable computer software for collecting, analyzing and organizing data in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence

  • Tote bags; umbrellas

  • Water bottles sold empty

  • Clothing for men, women and children, namely, shirts, t-shirts, jackets, tops, and sweat shirts

  • Promoting technical and scientific investigation, research, and experimentation in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; promoting the exchange of information and resources within the scientific and medical research community and the technology industry to achieve advances in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; administration and management of research grants; advertising services

  • Financial services, namely, providing grants and funding in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; funds investment, namely, fund investment services in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence

  • Educational services, namely, organizing and conducting conferences, courses, seminars, and training in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; educational services, namely, arranging and conducting seminars, workshops, colloquia, lectures, non-downloadable webinars, multimedia presentations and training in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; providing online databases for educational use purposes in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; publishing of non-downloadable electronic publications, namely, letters, newsletters, articles, news stories, blogs and fact sheets in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence

  • Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for use in model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; providing a website featuring non-downloadable software using artificial intelligence (AI) for use in model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; platform as a service (PAAS) services featuring software using artificial intelligence (AI) for use in model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; artificial intelligence as a service (AIAAS) featuring software using artificial intelligence (AI) for use in model development and distribution in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; providing a website featuring non-downloadable software using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; platform as a service (PAAS) services featuring software using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; artificial intelligence as a service (AIAAS) featuring software using artificial intelligence (AI) for use in machine learning in the fields of human biology, biomedical research, biotechnology, bioinformatics, and bioengineering; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; providing a website featuring non-downloadable software using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; platform as a service (PAAS) services featuring software using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; artificial intelligence as a service (AIAAS) featuring software using artificial intelligence (AI) for use in biological data processing, generation, understanding and analysis; research in the field of artificial intelligence (AI) software; research in the field of artificial intelligence technology; design and development of artificial intelligence (AI) software; development and design of computer software; research, development and design of biomedical technologies and products; design of genetic research tools and systems for others; developing new technology for others in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; technology services, namely, technological research and development in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; providing facilities for human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; providing information about human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; scientific research; medical research; biomedical research; biotechnology research; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; research and development services in the field of immunology; research and development in the field of microorganisms and cells; scientific research for medical purposes in the area of infectious, cancerous, and neurodegenerative diseases; research in the field of cell engineering technology; consulting services in the fields of human biology, biomedical research, biotechnology, bioinformatics, bioengineering, and artificial intelligence; computer software consulting; consultancy in the field of artificial intelligence (AI) technology; providing genetic sequencing and consulting services for medical research purposes

  • Genome sequencing services for scientific and research purposes; genetic testing for medical research purposes; medical diagnostic testing, monitoring and reporting services for research purposes

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/130 Section A.1
FAQ

About [O]

Who owns the trademark "[O]"?

The EUIPO trademark "[O]" (application 019326099) is owned by Chan Zuckerberg Initiative, LLC.

What is the status of "[O]"?

Its status at the EUIPO is: registered.

When was "[O]" registered?

It was registered on October 22, 2026 and is due to expire on March 5, 2036.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull [O] and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d48e3-674d-743f-bbf7-41c5e3a015b6
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d48e3-674d-743f-bbf7-41c5e3a015b6",
  "object": "trademark",
  "mark_text": "[O]",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019326099",
  "filing_date": "2026-03-05",
  "nice_classes": [
    9,
    18,
    21,
    25,
    35,
    36,
    41,
    42,
    44
  ],
  "owners": [
    {
      "name": "Chan Zuckerberg Initiative, LLC",
      "entity_id": "ent_019ebbba-1034-70b4-9091-94f34cf0b47f"
    }
  ]
}